skip to main content

Macrogol frailty CKD HF — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateRenal and Hepatic ImpairmentMacrogol frailty CKD HFGPhC CRA

A care-home resident with CKD and heart failure on high-dose macrogol develops increasing breathlessness. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Refer for clinical review before continuing high-dose treatment

This scenario assesses Macrogol frailty CKD HF in a UK pharmacy practice context. Fluid balance and frailty complicate high-dose laxative use, especially with heart failure and CKD. The best answer is Refer for clinical review before continuing high-dose treatment because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: https://www.pharmacyregulation.org/registration-assessment#stage-8-order-73